StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > We can expect a lot more...!

<< Previous

Bullboard Posts

Next >>

Post by RelevantStockon Feb 18, 2021 9:16pm

288 Views

Post# 32606130

We can expect a lot more...!

We have broken out of the 1.10 zone (and other levels after) with rapid buys of around 500-700k shares at most. I am expecting days with volume at least at 3-5M, maybe more, when we make the news for the launch of Aristotle, partnerships, revenue, etc. So happy of how we held this morning (and yesterday morning too). The new buyers here just arrived early for the front row tickets, much more to come.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec